Gene Query: RBSN

Dataset Description Geneva Score
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 37.66
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 14.23
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 14.23
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 13.04
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 12.71
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 12.31
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 10.37
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 10.11
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 10.11
RIG-I and MDA5 fRIP during KSHV lytic reactivation 9.88
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 9.86
Mitochondrial dsRNA triggers antiviral signalling in humans 9.83
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 9.83
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 9.56
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 9.38
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 9.29
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 9.24
IDH3a KO RNA-seq 9.21
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 9.04
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 8.91
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 8.89
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 8.77
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.75
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.75
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 8.56
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 8.5
Systematic discovery of endogenous human ribonucleoprotein complexes 8.35
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 8.0
PTHrP overexpression in MCF7 cells 7.95
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 7.94
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 7.76
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 7.56
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.4
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 7.24
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 7.24
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 7.07
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 7.02
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.88
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.88
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 6.65
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 6.62
Control of prostate tumour growth by the long non-coding RNA GHSROS 6.48
Downregulation of DDX5/DDX17 and REST 6.47
Gene expression analysis of dengue-infected cells 6.45
RNA sequencing of BT142 and TS603 cell lines 6.32
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 6.32
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 6.31
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 6.31
The evolution of N6-methyladenosine in primates 6.21
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.11
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 6.06
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 6.05
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 6.0
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 6.0
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 5.93
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 5.92
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 5.87
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 5.82
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 5.76
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 5.73
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.68
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 5.6
Ribosomal footprinting of CN34-Parental and CN34-LM1a 5.59
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.53
LINE-2 transposable elements are a source of functional human microRNAs and target sites 5.5
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 5.45
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 5.42
Transcriptional changes in lymphoma cells induced by LSD1 depletion 5.42
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 5.4
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 5.38
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 5.38
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 5.37
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 5.37
ETV7 and interferon response 5.36
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 5.36
Ribosomal footprinting of MDA-Parental and MDA-LM2 5.34
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 5.31
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 5.27
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 5.24
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 5.22
Examining serotonergic neuron differentiation from human iPSCs 5.22
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 5.17
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 5.17
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 5.13
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 5.1
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 5.09
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 5.08
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 5.0
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 5.0
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 4.99
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 4.96
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.96
RNA transcriptome analysis during HSV-1 infection 4.93
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.91
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 4.88
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 4.87
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 4.86
MicroRNA-125a-5p overexpression in human macrophages 4.81
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 4.81
SRSF2 mutations impair hematopoiesis and alter exon recognition 4.78
Zika infected neural stem cells 4.7
Transcriptome analysis of Zika infected neural stem cells 4.7
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 4.67
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 4.62
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 4.62
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.6
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 4.55
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 4.49
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.49
Tumor exosome integrins determine organotropic metastasis 4.41
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 4.38
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 4.35
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 4.34
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 4.33
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.33
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 4.31
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 4.27
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 4.26
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 4.26
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 4.24
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 4.22
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.2
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.2
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 4.19
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 4.18
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 4.18
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.17
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 4.15
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 4.12
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.12
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 4.11
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 4.11
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.07
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 4.01
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 4.01
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 3.99
Identification of global regulators of T-helper cell lineage specification 3.98
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.98
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 3.95
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.93
Tracking of dCas9-methyltransferase footprints 3.89
Effect of disulfiram treatment on pediatric high grade glioma 3.89
Cajal bodies are linked to genome conformation 3.87
Cajal bodies are linked to genome conformation [RNA-Seq] 3.87
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 3.87
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 3.85
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 3.84
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 3.83
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 3.82
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 3.8
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 3.78
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 3.77
SNHG5 siRNA knock down in HCT116 cells 3.76
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 3.75
Comparing gene expression in iPSC derived RPE from control and AMD donors 3.72
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 3.72
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 3.72
3’ Uridylation Expands miRNA Target Repertoire 3.71
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 3.69
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 3.68
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 3.67
Global analysis of alternative splicing regulated by RBM10 3.66
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 3.65
Altering cancer transcriptomes using epigenomic inhibitors 3.65
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 3.65
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 3.64
Patient-derived luminal breast cancer xenografts with progestins 3.64
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 3.62
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 3.62
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 3.61
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 3.59
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.59
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.59
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 3.57
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 3.55
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 3.54
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 3.54
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 3.54
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.49
Capturing the Interactome of Newly Transcribed RNA 3.49
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.48
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.48
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 3.47
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 3.47
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 3.46
Dtx3L and Androgen Signaling in Prostate Cancer 3.46
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 3.46
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.46
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 3.46
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 3.45
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 3.45
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 3.43
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 3.43
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 3.42
Gene expression in GBM with Cav3.2 inhibition 3.42
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.39
Studying the selectivity of a small molecule Synucleozid on transcriptome 3.37
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.36
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 3.34
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.34
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 3.34
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 3.34
circRNA-sequencing 3.32
Global transcriptome analysis of HAP1 cells 3.3
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.3
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 3.29
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 3.28
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 3.26
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 3.26
Transcriptome analysis of U87 cells upon LINC00152 knockdown 3.25
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.2
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.2
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 3.2
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 3.18
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.16
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 3.15
Disruption of the exocyst induces podocyte loss and dysfunction 3.15
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.14
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.13
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 3.13
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.12
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.12
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 3.1
IRF1 regulates IFN dependent and independent gene expression 3.09
PRDM1 inhibits proliferation of human colon cancer organoids 3.08
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 3.06
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 3.06
SLIGRL-induced gene expression changes in NHEK cells 3.04
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.03
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 2.98
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.96
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 2.95
Gene expression profile in breast cancer cell lines using RNA sequencing 2.94
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 2.93
Role of XRN2 ribonucleolytic activity in RNA metabolism 2.92
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 2.92
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 2.91
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 2.87
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 2.86
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.85
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.85
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 2.83
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.82
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 2.82
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 2.8
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 2.77
Identification of global XBP1s target gene expression in human prostate cancer cells 2.77
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 2.76
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 2.76
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 2.74
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 2.73
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 2.73
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 2.72
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 2.72
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 2.72
Total RNA sequencing of APC mutant and wt colonic organoids 2.7
RNA-seq data 2.69
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 2.67
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 2.67
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 2.65
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 2.65
HNRNPL and its RNA Targets in Prostate Cancer 2.65
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 2.65
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 2.65
RNA expression analysis upon JMJD1C depletion 2.65
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 2.65
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 2.64
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.62
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.62
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 2.58
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 2.58
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.54
FOXP1 orchestration of ASD-relevant signaling pathways. 2.53
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 2.51
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 2.51
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 2.49
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 2.48
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 2.48
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.45
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.43
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.42
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.37
Differential responses of human fetal brain neural stem cells to Zika virus infection 2.37
Human cell line and subcutaneous tumor 2.36
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 2.36
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 2.36
Identification of renal resident macrophages across species [C1] 2.35
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 2.35
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 2.34
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.31
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.28
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.28
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.26
Effect of drugs on transcriptomic profiles 2.26
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 2.24
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.22
Real-time observation of light-controlled transcription in living cells 2.21
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 2.21
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.15
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 2.15
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.14
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.14
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.13
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.12
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.11
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.08
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.08
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 2.06
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 2.05
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.04
Controlling for gene expression changes in transcription factor protein networks. 2.02
Dissecting neural differentiation regulatory networks through epigenetic footprinting 1.97
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.96
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 1.96
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 1.93
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.92
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.92
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 1.91
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.91
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.89
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.86
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.85
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 1.85
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 1.85
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.83
Transcriptional profile in human S. haematobium infection 1.83
RNAseq in Alzheimer's Disease patients 1.78
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.74
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 1.74
Gene expression analysis upon mtDNA depletion 1.73
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.73
METTL3 and WTAP 1.72
mRNA expression profile of Lymphocytes by high-throuput sequencing 1.71
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.7
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.7
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 1.67
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 1.64
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 1.64
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.63
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.63
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.63
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 1.61
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.6
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.6
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 1.56
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 1.53
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 1.53
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 1.49
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 1.49
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.49
Biological effect of chronic mistranslation in mammalian cells 1.48
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.46
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.46
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.46
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.44
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.42
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.42
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.41
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.38
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.36
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.35
Functional astrocytes differentiated from hiPSCs 1.33
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.32
HEK293 TFAM Knockout Expression Study 1.3
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.28
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 1.28
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.27
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.26
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.26
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.25
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.25
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.25
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.24
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 1.24
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.23
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 1.23
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.23
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.23
Determining mRNA half-lives on a transcriptome-wide scale 1.23
Genome-wide discovery of human splicing branchpoints [RNAse] 1.21
Measure transcript integrity using RNA-seq data 1.19
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.18
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.18
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.16
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.15
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 1.14
Identification of renal resident macrophages across species 1.14
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 1.12
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 1.12
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.11
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.09
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.09
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 1.08
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.08
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.06
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.02
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.0
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.0
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 0.98
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 0.95
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.95
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.94
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.94
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.93
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.93
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.91
p53 activity results in DNA replication fork processivity 0.88
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.87
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.86
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.84
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.81
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.8
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.78
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.76
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.75
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.72
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.72
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.72
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.71
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 0.71
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.69
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 0.68
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.68
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.63
UV_24h_GRO-Seq 0.63
Gene expression changes after LOC550643 silencing 0.62
Transposon-based construction of strand-specific RNA-seq libraries 0.6
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.59
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.58
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.57
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.57
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.52
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 0.52
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.52
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 0.52
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.51
Oncogenic roles of ARID5B in T-ALL 0.5
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.5
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.47
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.47
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 0.45
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.44
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.44
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.44
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.44
RNA-seq of tumor cells following angiopellosis extravasation 0.43
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.43
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.43
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 0.42
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 0.42
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.42
The Glioma-Infiltrating T Cell Receptor Repertoire 0.39
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.38
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.38
High-resolution comparative analysis of great ape genomes 0.37
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.29
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.28
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.27
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.26
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.25
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.25
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.22
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.22
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.22
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.21
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.21
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.2
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 0.15
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.15
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.13
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.1
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 0.09
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 0.09
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.09
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.09
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.09
Ribosomal protein RPL26 is the principal target of UFMylation 0.09
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.09
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.09
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.08
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.07
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.07
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.07
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.07
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.06
Genome-wide analysis of the Integrator complex (HTS) 0.06
Genome-wide analysis of the Integrator complex 0.06
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.06
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.06
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.06
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.05
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.03
Role of FGFR1 in neuronal devlopment 0.03
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.01
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.01
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.01
Comparative Analysis of Cas9 Activators Across Multiple Species 0.01
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.0
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.0
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation